循环溶性LOX-1和急性冠状动脉综合征后的患者预后
Alexandru Schiopu1,2, Sara Svedlund3,4, Gayathri Narasimhan5
1Department of Translational Medicine, Lund University, Malmö, Sweden Alexandru.Schiopu@med.lu.se.
Heart (British Cardiac Society)
|September 16, 2025
概括
在急性冠状动脉综合征 (ACS) 患者中,可溶性莱克类氧化低密度脂蛋白受体-1 (sLOX-1) 的升高预测心力衰竭和主要心血管不良事件. sLOX-1还表明心脏功能障碍,支持LOX-1作为治疗点.
科学领域:
- 心血管研究研究心血管研究
- 生物标志物发现发现
- 炎症生物学 炎症生物学
背景情况:
- 莱克类氧化低密度脂蛋白受体-1 (LOX-1) 与动脉样硬化斑块炎症有关.
- 溶性LOX-1 (sLOX-1),从激活的LOX-1中脱落,在急性冠状动脉综合征 (ACS) 中升高.
研究的目的:
- 评估血sLOX-1水平与心力衰竭 (HF),主要不良心血管事件 (MACE) 和ACS患者心脏功能障碍的发展之间的关联.
- 为了研究LOX-1阻断的体外抗炎作用.
主要方法:
- 在两个ACS患者队列 (n=524和n=363) 中进行前性评估.
- 评估sLOX-1与发生的HF,MACE,冠状动脉和左心室 (LV) 功能障碍之间的关联.
- 使用人类静脉内皮细胞 (HUVEC) 进行体外研究,以检查LOX-1阻塞效应.
主要成果:
- 在第一个队列中,sLOX-1独立地与事件HF和MACE相关.
- 升高的sLOX-1与较低的LV喷射率和加速的LV改造相关.
- 在第二组中,sLOX-1与冠状动脉流量储备受损,心血管静脉缩功能下降以及炎症和心脏过载的标志物有关.
结论:
- 血sLOX-1升高是ACS患者高血压,MACE和心脏功能障碍的重要预测因素.
- sLOX-1水平可能反映LOX-1在血管和免疫细胞的表达强度.
- 这些发现突出了LOX-1作为改善ACS.结果的潜在治疗标.
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
01:30Acute Coronary Syndrome I: Introduction
828
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828
01:26Coronary Artery Disease II: Pathophysiology
375
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
375